Gao P - Search Results

1

ZEB1 expression is correlated with tumor metastasis and reduced prognosis of breast carcinoma in Asian patients.

Xiang S, Liu YM, Chen X, Wang YW, Ma RR, Wu XJ, Gao P. Xiang S, et al. Among authors: gao p. Cancer Invest. 2015 Jul;33(6):225-31. doi: 10.3109/07357907.2015.1022258. Epub 2015 May 7. Cancer Invest. 2015. PMID: 25950745

2

[Expression of mucin 1 and tumor invasiveness in breast carcinoma].

Gao P, Zhou GY, Zhang QH, Xiang L, Ma C, Yu HP, Yu F. Gao P, et al. Zhonghua Yi Xue Za Zhi. 2005 Feb 16;85(6):381-4. Zhonghua Yi Xue Za Zhi. 2005. PMID: 15854526 Chinese.

3

Lymphatic vessel density as a prognostic indicator for patients with stage I cervical carcinoma.

Gao P, Zhou GY, Yin G, Liu Y, Liu ZY, Zhang J, Hao CY. Gao P, et al. Hum Pathol. 2006 Jun;37(6):719-25. doi: 10.1016/j.humpath.2006.01.025. Hum Pathol. 2006. PMID: 16733213

4

Reversal of drug resistance in breast carcinoma cells by anti-mdr1 ribozyme regulated by the tumor-specific MUC-1 promoter.

Gao P, Zhou GY, Guo LL, Zhang QH, Zhen JH, Fang AJ, Lin XY. Gao P, et al. Cancer Lett. 2007 Oct 18;256(1):81-9. doi: 10.1016/j.canlet.2007.06.005. Epub 2007 Jul 16. Cancer Lett. 2007. PMID: 17637500

5

Clinicopathological significance of peritumoral lymphatic vessel density in gastric carcinoma.

Gao P, Zhou GY, Zhang QH, Xiang L, Zhang SL, Li C, Sun YL. Gao P, et al. Cancer Lett. 2008 May 18;263(2):223-30. doi: 10.1016/j.canlet.2008.01.017. Epub 2008 Mar 4. Cancer Lett. 2008. PMID: 18289774

6

Lymphangiogenesis in gastric carcinoma correlates with prognosis.

Gao P, Zhou GY, Zhang QH, Su ZX, Zhang TG, Xiang L, Wang Y, Zhang SL, Mu K. Gao P, et al. J Pathol. 2009 Jun;218(2):192-200. doi: 10.1002/path.2523. J Pathol. 2009. PMID: 19224540

7

Promoter methylation of glutathione S-transferase pi1 and multidrug resistance gene 1 in bronchioloalveolar carcinoma and its correlation with DNA methyltransferase 1 expression.

Gao P, Yang X, Xue YW, Zhang XF, Wang Y, Liu WJ, Wu XJ. Gao P, et al. Cancer. 2009 Jul 15;115(14):3222-32. doi: 10.1002/cncr.24369. Cancer. 2009. PMID: 19484794 Free article.

8

Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi).

Zhang X, Li J, Qiu Z, Gao P, Wu X, Zhou G. Zhang X, et al. Among authors: gao p. Cancer Biol Ther. 2009 Jun;8(12):1117-21. doi: 10.4161/cbt.8.12.8374. Epub 2009 Jun 9. Cancer Biol Ther. 2009. PMID: 19502811 Free article.

9

Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs.

Sun Y, Zhang T, Gao P, Meng B, Gao Y, Wang X, Zhang J, Wang H, Wu X, Zheng W, Zhou G. Sun Y, et al. Among authors: gao y, gao p. Breast Cancer Res Treat. 2010 Jun;121(3):591-9. doi: 10.1007/s10549-009-0513-z. Epub 2009 Aug 20. Breast Cancer Res Treat. 2010. PMID: 19693666

10

MDR1 (multidrug resistence 1) can regulate GCS (glucosylceramide synthase) in breast cancer cells.

Zhang X, Wu X, Li J, Sun Y, Gao P, Zhang C, Zhang H, Zhou G. Zhang X, et al. Among authors: gao p. J Surg Oncol. 2011 Oct;104(5):466-71. doi: 10.1002/jso.21958. Epub 2011 May 2. J Surg Oncol. 2011. PMID: 21538359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,251 results

Search Page

Filters